We help to place your technology in the strongest position to withstand scrutiny from any HTA body and optimise the likelihood of a positive recommendation for reimbursement.
Our HTA service offerings span early HTA planning and strategy, the generation of HTA-standard literature reviews, statistical analysis and real-world evidence, and the development of the highest quality HTA submission dossiers and associated health economic models.
260+
HTA Submission Dossiers
110+
HTA Submission Dossiers to NICE
150+
HTA SUBMISSION DOSSIERS across Europe, North America and APAC
Our dedicated HTA team are true experts when it comes to devising the optimal strategy for your technology, generating a robust HTA-ready evidence package, and delivering the highest quality HTA submission dossiers.
To date, we have supported the development of over 260 health technology assessment (HTA) submission dossiers, including over 110 submission dossiers to NICE, and over 150 submission dossiers across Europe (Scotland, Wales, Ireland, Sweden, Greece, Belgium, Spain), North America (CADTH, AMCP) and the APAC region (Singapore).
We deliver a fully comprehensive HTA evidence package that places your technology in the strongest position to withstand scrutiny from any HTA body and optimises the likelihood of a positive recommendation for reimbursement. Our service offerings cover early gap analyses and scientific advice, the generation of HTA-standard literature reviews, statistical analysis and real-world evidence, and ultimately the development of the highest quality HTA submission dossiers and associated health economic models.
Complete HTA submission dossier development, including project and stakeholder management
We work as one internal team to deliver all components of your HTA evidence package. We firmly believe that in doing so we can offer a solution that is not only more efficient, but that also results in a strong, consistent and self-reinforcing HTA narrative throughout the HTA submission dossier.
We are experienced in advising clients on wide-ranging strategic HTA challenges, such as immature survival data and uncertainty in long-term clinical effectiveness, lack of data for relevant comparators and the use of real-world evidence, difficulties in demonstrating cost-effectiveness at the desired price, and the use of the most appropriate methods for indirect treatment comparison.
Our extensive experience in writing for HTA, coupled with thorough postgraduate-level training in health economics received by most of our medical writers, makes us ideally placed to seamlessly weave together the clinical and economic stories within your HTA submission dossier, and develop a clear, evidence-based and persuasive narrative.
We genuinely care about the outcome of our clients’ HTA submissions as much as they do. We aim to become an integral part of the client team, providing technical expertise and the highest quality deliverables to form the complete HTA evidence package alongside proactive and responsible project management support.
We have a dedicated Rare Diseases team who specialise in the delivery of HTA evidence generation and submission dossier delivery in the rare diseases space. We also provide guidance on engaging with patients/patient organisations throughout the appraisal process. Beyond pharmaceuticals, we have experience in the delivery of early HTA planning and strategy, HTA evidence generation, economic modelling and HTA submission dossier writing for devices and diagnostics, in collaboration with our MedTech team.
We are keen contributors of research on key advances in HTA methods and processes at international conferences, including posters, oral presentations, workshops, and issue panels presented at ISPOR and HTAi. Explore our dedicated pages to find out more.
At the start of 2025, NICE has consulted on a new modular update to its manual for technology evaluations. This update is focused on how evidence for impact of a new intervention on health inequalities can be submitted to NICE and how this can influence NICE Committee decision-making.
